US$ 28.46
is mounjaro a glp-1 agonist glp 1 drug Mounjaro Tirzepatide Gip Receptor Stock Photo 2453657649 is mounjaro a glp-1 drug
Description
Gastrointestinal effects remain the most common complaint
It is also not recommended for patients with existing gastrointestinal disease to avoid potential side effects or exacerbating the condition

Kushner, R

If youre looking for a less costly alternative to a medication like semaglutide, you can explore other GLP-1 agonist options

The STEP trials are testing semaglutide at the higher dose of 2.4 mg/week (as compared to 1.0 mg/week for the original diabetes indication), specifically for promoting weight loss, regardless of the presence of type 2 diabetes

2024 State Action Late last year, Illinois adopted a bill to cover certain weight loss and obesity medicines, including GLP-1s, under the state employee health plan
